During tumor progression, MCs accumulate near blood vessels located around the tumor, secreting several mediators promoting angiogenesis and suppressing the immune response, including vascular endothelial growth factor (VEGF), histamine, tumor necrosis factors (TNF-α), and interleukin 18 (IL-18) [4]. The gene discussed is VEGFA; the disease is neoplasm.